Leap Therapeutics (LPTX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

LPTX is expected to report earnings to fall 72.50% to -8 cents per share on August 11

Leap Therapeutics LPTX Stock Earnings Reports

Q2'23

Est.

$-0.09

Q1'23

Missed

by $0.23

Q4'22

Est.

$-0.11

Q3'22

Missed

by $0.01

Q2'22

Missed

by $0.05

The last earnings report on May 15 showed earnings per share of -31 cents, missing the estimate of -8 cents. With 74.39K shares outstanding, the current market capitalization sits at 103.31M.

View a ticker or compare two or three

Compare

LPTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For LPTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in clinical stage immuno-oncology

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

47 Thorndike Street

Phone

+1 617 714-0360

Employees

Web

https://www.leaptx.com